RxDoctor Payments Data

Jeffrey Arkles, MD

Clinical Cardiac Electrophysiology · Lancaster, PANPI 1841405222

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 46.6% of the total. Reporting peaked in 2019 at $29,381 and has fallen 79.4% since, to $6,054 in 2025.

$48,006in general payments, 2019–2025

Across 296 payments — averaging $162.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$22K
  • Medical Device Business Services, Inc.$8K
  • Medtronic$4K
  • Boston Scientific$4K
  • Varian Medical Systems, Inc.$4K
  • Baylis Medical Company Inc$2K
  • plus $4K from 12 others
$86,313in research payments, 2019–2025

Across 17 payments — averaging $5077.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$86K

What the payments were for

  • Consulting fees$23,67549%
  • Speaking & faculty fees$4,1759%
  • Travel & lodging$8,31517%
  • Food & beverage$11,84125%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,006 in reported general payments places this provider in the 75th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$366,987
Medicare patients
2,406
Services billed
5,088

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$128,684
XareltoRivaroxaban30$35,251
MultaqDronedarone Hcl18$22,224
Flecainide Acetate73$3,013
Metoprolol Succinate176$2,660
Amiodarone Hcl69$1,224
SotalolSotalol Hcl47$580
Olmesartan Medoxomil17$488
Rosuvastatin Calcium23$356
Diltiazem 24hr Er (Cd)Diltiazem Hcl26$194
Atorvastatin Calcium14$180
Carvedilol39$146
Losartan Potassium13$144
Metoprolol Tartrate33$132
Amlodipine Besylate26$55

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →